ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
A phase II study of ixabepilone and trastuzumab for metastatic HER2-positive breast cancer
Annals of Oncology
◽
10.1093/annonc/mdt121
◽
2013
◽
Vol 24
(7)
◽
pp. 1841-1847
◽
Cited By ~ 3
Author(s):
S.M. Tolaney
◽
J. Najita
◽
J. Sperinde
◽
W. Huang
◽
W.Y. Chen
◽
...
Keyword(s):
Breast Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Her2 Positive
◽
Her2 Positive Breast Cancer
◽
Positive Breast Cancer
Download Full-text
Related Documents
Cited By
References
Faculty Opinions recommendation of Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.724195112.793501041
◽
2014
◽
Author(s):
Minesh Mehta
◽
Manmeet Ahluwalia
Keyword(s):
Breast Cancer
◽
Brain Metastases
◽
Phase Ii
◽
Phase Ii Study
◽
Her2 Positive
◽
Her2 Positive Breast Cancer
◽
Multicenter Phase
◽
Positive Breast Cancer
Download Full-text
All-oral combination of lapatinib and capecitabine in patients with brain metastases from HER2-positive breast cancer – A phase II study
Journal of the Egyptian National Cancer Institute
◽
10.1016/j.jnci.2014.08.001
◽
2014
◽
Vol 26
(4)
◽
pp. 187-194
◽
Cited By ~ 9
Author(s):
Hanan Shawky
◽
Hesham Tawfik
Keyword(s):
Breast Cancer
◽
Brain Metastases
◽
Phase Ii
◽
Phase Ii Study
◽
Her2 Positive
◽
Her2 Positive Breast Cancer
◽
Positive Breast Cancer
Download Full-text
Abstract OT1-1-09: Opti-HER HEART: A prospective, multicenter, single-arm, phase II study to evaluate the safety of neoadjuvant liposomal doxorubicin plus paclitaxel, trastuzumab, and pertuzumab in patients with operable HER2-positive breast cancer.
10.1158/0008-5472.sabcs12-ot1-1-09
◽
2012
◽
Author(s):
J Gavilá
◽
A Llombart
◽
A Guerrero
◽
A Ruiz
◽
V Guillem
Keyword(s):
Breast Cancer
◽
Phase Ii
◽
Liposomal Doxorubicin
◽
Phase Ii Study
◽
Her2 Positive
◽
Her2 Positive Breast Cancer
◽
Positive Breast Cancer
Download Full-text
Multicenter Phase II Study of Lapatinib in Patients with Brain Metastases from HER2-Positive Breast Cancer
Clinical Cancer Research
◽
10.1158/1078-0432.ccr-08-1080
◽
2009
◽
Vol 15
(4)
◽
pp. 1452-1459
◽
Cited By ~ 429
Author(s):
Nancy U. Lin
◽
Véronique Diéras
◽
Devchand Paul
◽
Dominique Lossignol
◽
Christos Christodoulou
◽
...
Keyword(s):
Breast Cancer
◽
Brain Metastases
◽
Phase Ii
◽
Phase Ii Study
◽
Her2 Positive
◽
Her2 Positive Breast Cancer
◽
Multicenter Phase
◽
Positive Breast Cancer
Download Full-text
LCCC 1025: a phase II study of everolimus, trastuzumab, and vinorelbine to treat progressive HER2-positive breast cancer brain metastases
Breast Cancer Research and Treatment
◽
10.1007/s10549-018-4852-5
◽
2018
◽
Vol 171
(3)
◽
pp. 637-648
◽
Cited By ~ 14
Author(s):
Amanda E. D. Van Swearingen
◽
Marni B. Siegel
◽
Allison M. Deal
◽
Maria J. Sambade
◽
Alan Hoyle
◽
...
Keyword(s):
Breast Cancer
◽
Brain Metastases
◽
Phase Ii
◽
Phase Ii Study
◽
Her2 Positive
◽
Her2 Positive Breast Cancer
◽
Breast Cancer Brain Metastases
◽
Positive Breast Cancer
Download Full-text
S5-1: Neoadjuvant Pertuzumab (P) and Trastuzumab (H): Biomarker Analyses of a 4-Arm Randomized Phase II Study (NeoSphere) in Patients (pts) with HER2−Positive Breast Cancer (BC).
10.1158/0008-5472.sabcs11-s5-1
◽
2011
◽
Cited By ~ 10
Author(s):
L Gianni
◽
G Bianchini
◽
A Kiermaier
◽
G Bianchi
◽
Y-H Im
◽
...
Keyword(s):
Breast Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Her2 Positive
◽
Her2 Positive Breast Cancer
◽
Randomized Phase Ii
◽
Positive Breast Cancer
Download Full-text
Abstract P2-16-02: Bevacizumab, etoposide, and cisplatin (BEEP) is highly effective in brain metastases of HER2 positive breast cancer progressing from whole brain radiotherapy - Subgroup analysis of a multi-center phase II study
10.1158/0008-5472.sabcs13-p2-16-02
◽
2013
◽
Author(s):
Y-S Lu
◽
W-W Chen
◽
C-H Lin
◽
D-C Yeh
◽
L-M Tseng
◽
...
Keyword(s):
Breast Cancer
◽
Brain Metastases
◽
Phase Ii
◽
Subgroup Analysis
◽
Phase Ii Study
◽
Whole Brain Radiotherapy
◽
Her2 Positive
◽
Her2 Positive Breast Cancer
◽
Brain Radiotherapy
◽
Positive Breast Cancer
Download Full-text
Abstract GS1-05: TBCRC 033: A randomized phase II study of adjuvant trastuzumab emtansine (T-DM1) vs paclitaxel (T) in combination with trastuzumab (H) for stage I HER2-positive breast cancer (BC) (ATEMPT)
10.1158/1538-7445.sabcs19-gs1-05
◽
2020
◽
Cited By ~ 1
Author(s):
Sara M Tolaney
◽
Lorenzo Trippa
◽
William Barry
◽
Jiani Hu
◽
Chau Dang
◽
...
Keyword(s):
Breast Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Stage I
◽
Trastuzumab Emtansine
◽
Her2 Positive
◽
Adjuvant Trastuzumab
◽
Her2 Positive Breast Cancer
◽
Randomized Phase Ii
◽
Positive Breast Cancer
Download Full-text
Randomized Phase II Study of Primary Systemic Chemotherapy and Trastuzumab for Operable HER2 Positive Breast Cancer
Clinical Breast Cancer
◽
10.1016/j.clbc.2011.10.002
◽
2012
◽
Vol 12
(1)
◽
pp. 49-56
◽
Cited By ~ 7
Author(s):
Seigo Nakamura
◽
Masashi Ando
◽
Norikazu Masuda
◽
Kenjiro Aogi
◽
Hiroyo Ino
◽
...
Keyword(s):
Breast Cancer
◽
Phase Ii
◽
Systemic Chemotherapy
◽
Phase Ii Study
◽
Her2 Positive
◽
Her2 Positive Breast Cancer
◽
Primary Systemic Chemotherapy
◽
Randomized Phase Ii
◽
Positive Breast Cancer
Download Full-text
Abstract S1-04: A phase II study of adjuvant paclitaxel (T) and trastuzumab (H) (APT trial) for node-negative, HER2-positive breast cancer (BC)
10.1158/0008-5472.sabcs13-s1-04
◽
2013
◽
Cited By ~ 13
Author(s):
SM Tolaney
◽
WT Barry
◽
CT Dang
◽
DA Yardley
◽
B Moy
◽
...
Keyword(s):
Breast Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Her2 Positive
◽
Node Negative
◽
Her2 Positive Breast Cancer
◽
Positive Breast Cancer
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close